Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease

BackgroundAngiography-derived microcirculatory resistance (AMR) is proposed as a novel, pressure- temperature-wire-free and less-invasive method to evaluate coronary microvascular dysfunction (CMD). This study aims to examine the prognostic role of CMD assessed by AMR in predicting adverse events in...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyu Guo, Yike Li, Qiang Chen, Jingang Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1489403/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556697217236992
author Ziyu Guo
Yike Li
Qiang Chen
Jingang Zheng
Jingang Zheng
author_facet Ziyu Guo
Yike Li
Qiang Chen
Jingang Zheng
Jingang Zheng
author_sort Ziyu Guo
collection DOAJ
description BackgroundAngiography-derived microcirculatory resistance (AMR) is proposed as a novel, pressure- temperature-wire-free and less-invasive method to evaluate coronary microvascular dysfunction (CMD). This study aims to examine the prognostic role of CMD assessed by AMR in predicting adverse events in acute coronary syndrome (ACS) patients with chronic kidney disease (CKD).MethodsThis retrospective cohort study included ACS with CKD patients in the China-Japan Friendship Hospital from January 2016 to November 2022. The patients were divided into CMD and non-CMD groups based on AMR values of less than or greater than 250 mmHg*s/m.ResultsA total of 345 eligible patients were included in this study. During a median follow-up of 23.0 months, higher prevalence rate of MACEs (28.3% vs. 15.1%, P = 0.003) and death (20.2% vs. 4.1%, P = 0.001) were observed in the CMD group. In multivariate Cox regression analysis, patients in the group of CMD had a 1.843 times higher hazard ratio (HR) for developing MACEs (HR: 1.843, 95% CI: 1.071–3.174, P = 0.027) and 5.325 times higher HR for developing death (HR: 5.325, 95% CI: 1.979–14.327, P < 0.001) for every 10 mmHg*s/m increment in AMR. The incorporation of AMR improved the predictive accuracy of the GRACE score for MACEs and death.ConclusionThis study indicates that the AMR is significantly related to poor prognosis among patients with ACS and CKD. Furthermore, AMR could improve the predictive power of the GRACE risk score. These results indicated that AMR may serve as a valuable clinical tool for classification, risk stratification or therapy individualization in these patients.
format Article
id doaj-art-16009019b1134f629d5c31a3183800bf
institution Kabale University
issn 2297-055X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-16009019b1134f629d5c31a3183800bf2025-01-07T06:40:58ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-01-011110.3389/fcvm.2024.14894031489403Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney diseaseZiyu Guo0Yike Li1Qiang Chen2Jingang Zheng3Jingang Zheng4Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, ChinaDepartment of Cardiology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaGraduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, ChinaDepartment of Cardiology, China-Japan Friendship Hospital, Beijing, ChinaBackgroundAngiography-derived microcirculatory resistance (AMR) is proposed as a novel, pressure- temperature-wire-free and less-invasive method to evaluate coronary microvascular dysfunction (CMD). This study aims to examine the prognostic role of CMD assessed by AMR in predicting adverse events in acute coronary syndrome (ACS) patients with chronic kidney disease (CKD).MethodsThis retrospective cohort study included ACS with CKD patients in the China-Japan Friendship Hospital from January 2016 to November 2022. The patients were divided into CMD and non-CMD groups based on AMR values of less than or greater than 250 mmHg*s/m.ResultsA total of 345 eligible patients were included in this study. During a median follow-up of 23.0 months, higher prevalence rate of MACEs (28.3% vs. 15.1%, P = 0.003) and death (20.2% vs. 4.1%, P = 0.001) were observed in the CMD group. In multivariate Cox regression analysis, patients in the group of CMD had a 1.843 times higher hazard ratio (HR) for developing MACEs (HR: 1.843, 95% CI: 1.071–3.174, P = 0.027) and 5.325 times higher HR for developing death (HR: 5.325, 95% CI: 1.979–14.327, P < 0.001) for every 10 mmHg*s/m increment in AMR. The incorporation of AMR improved the predictive accuracy of the GRACE score for MACEs and death.ConclusionThis study indicates that the AMR is significantly related to poor prognosis among patients with ACS and CKD. Furthermore, AMR could improve the predictive power of the GRACE risk score. These results indicated that AMR may serve as a valuable clinical tool for classification, risk stratification or therapy individualization in these patients.https://www.frontiersin.org/articles/10.3389/fcvm.2024.1489403/fullcoronary microvascular dysfunctionangiography-derived microvascular resistance (AMR)acute coronary syndromechronic kidney diseaseMACEsall-cause mortality
spellingShingle Ziyu Guo
Yike Li
Qiang Chen
Jingang Zheng
Jingang Zheng
Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
Frontiers in Cardiovascular Medicine
coronary microvascular dysfunction
angiography-derived microvascular resistance (AMR)
acute coronary syndrome
chronic kidney disease
MACEs
all-cause mortality
title Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
title_full Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
title_fullStr Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
title_full_unstemmed Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
title_short Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease
title_sort prognostic impact of coronary microvascular dysfunction assessed by amr in acute coronary syndrome patients with chronic kidney disease
topic coronary microvascular dysfunction
angiography-derived microvascular resistance (AMR)
acute coronary syndrome
chronic kidney disease
MACEs
all-cause mortality
url https://www.frontiersin.org/articles/10.3389/fcvm.2024.1489403/full
work_keys_str_mv AT ziyuguo prognosticimpactofcoronarymicrovasculardysfunctionassessedbyamrinacutecoronarysyndromepatientswithchronickidneydisease
AT yikeli prognosticimpactofcoronarymicrovasculardysfunctionassessedbyamrinacutecoronarysyndromepatientswithchronickidneydisease
AT qiangchen prognosticimpactofcoronarymicrovasculardysfunctionassessedbyamrinacutecoronarysyndromepatientswithchronickidneydisease
AT jingangzheng prognosticimpactofcoronarymicrovasculardysfunctionassessedbyamrinacutecoronarysyndromepatientswithchronickidneydisease
AT jingangzheng prognosticimpactofcoronarymicrovasculardysfunctionassessedbyamrinacutecoronarysyndromepatientswithchronickidneydisease